迪瑞醫療(300396.SZ):擬終止回購公司股份事項 已累計回購1.05%股份
格隆匯5月10日丨迪瑞醫療(300396.SZ)公佈,公司於2022年5月10日召開第五屆董事會第十二次臨時會議及第五屆監事會第五次臨時會議審議通過了《關於終止回購公司股份的議案》,公司決定終止回購公司股份事項。
截至公吿日,公司以集中競價交易方式累計回購股份288.71萬股,佔公司總股本的1.05%,最高成交價為19.09元/股,最低成交價為15.29元/股,累計支付的總金額為5000.05萬元(不含交易費用)。
公司實際回購資金總額已達回購方案中回購資金總額的下限,且不超過回購方案中回購資金總額的上限。同時,考慮到公司業務發展的實際經營需求,為保證公司運營資金充足,以支撐業務拓展所需,因此,公司經慎重考慮決定終止實施此次回購公司股份事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.